Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
出版年份 2014 全文链接
标题
Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 136, Issue 10, Pages 2352-2360
出版商
Wiley
发表日期
2014-10-29
DOI
10.1002/ijc.29297
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9
- (2014) Qiaojia Huang et al. Molecular Cancer
- K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5
- (2014) Kuzhuvelil B Harikumar et al. NATURE IMMUNOLOGY
- Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer
- (2014) Ji-Won Kim et al. Cancer Research and Treatment
- Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro
- (2013) A. Danesh et al. BLOOD
- Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
- (2013) Kimberly R. Jordan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy for advanced melanoma: Fulfilling the promise
- (2013) Helen Gogas et al. CANCER TREATMENT REVIEWS
- Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
- (2013) B. Weide et al. CLINICAL CANCER RESEARCH
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
- (2013) Thomas F Gajewski et al. CURRENT OPINION IN IMMUNOLOGY
- Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
- (2013) Bastian Schilling et al. INTERNATIONAL JOURNAL OF CANCER
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- On the armament and appearances of human myeloid-derived suppressor cells
- (2012) Isabel Poschke et al. CLINICAL IMMUNOLOGY
- The role of CXCR3 and CXCR4 in colorectal cancer metastasis
- (2012) Teppei Murakami et al. INTERNATIONAL JOURNAL OF CANCER
- International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?
- (2012) Friederike Erdmann et al. INTERNATIONAL JOURNAL OF CANCER
- Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
- (2012) Joannes FM Jacobs et al. LANCET ONCOLOGY
- New insights into chronic inflammation-induced immunosuppression
- (2012) Julia Kanterman et al. SEMINARS IN CANCER BIOLOGY
- Melanoma-induced immunosuppression and its neutralization
- (2012) Viktor Umansky et al. SEMINARS IN CANCER BIOLOGY
- Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
- (2011) Paola Filipazzi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Two Faces of Interferon- in Cancer
- (2011) M. R. Zaidi et al. CLINICAL CANCER RESEARCH
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas
- (2010) Blanche Ka Ki Lo et al. AMERICAN JOURNAL OF PATHOLOGY
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Myeloid-derived suppressor cell heterogeneity and subset definition
- (2010) Elisa Peranzoni et al. CURRENT OPINION IN IMMUNOLOGY
- Chemokines in cancer related inflammation
- (2010) Paola Allavena et al. EXPERIMENTAL CELL RESEARCH
- Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment
- (2010) Paolo A Ascierto et al. Journal of Translational Medicine
- Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
- (2010) Thomas Condamine et al. TRENDS IN IMMUNOLOGY
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- The Liver Is a Site for Tumor-Induced Myeloid-Derived Suppressor Cell Accumulation and Immunosuppression
- (2009) Dan Ilkovitch et al. CANCER RESEARCH
- Regulatory T-Cell-Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma
- (2009) T. Nicholaou et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- The good and the bad of chemokines/chemokine receptors in melanoma
- (2009) Ann Richmond et al. Pigment Cell & Melanoma Research
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
- (2008) Shuiping Tu et al. CANCER CELL
- Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?
- (2008) Ron N. Apte et al. IMMUNOLOGICAL REVIEWS
- Melanoma and innate immunity – Active inflammation or just erroneous attraction?
- (2008) Alexander A. Navarini-Meury et al. SEMINARS IN CANCER BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started